Home/Biofrontera/Samantha Widdicombe

SW

Samantha Widdicombe

Senior Vice President of Sales & Marketing

Therapeutic Areas

Biofrontera Pipeline

Drug	Indication	Phase
BF-200 ALA (Ameluz®)	Actinic Keratosis - Pharmacokinetics	N/A (Post-Approval)

Leadership Team at Biofrontera

Prof. Hermann Luebbert, PhD

Chief Financial Officer

Chief Commercial Officer

Jon Lyons, PhD, MBA

Vice President of Scientific & Medical Affairs

View full Biofrontera profile